Biohaven announces preliminary 2q2021 net product revenue for nurtec odt, the first and only migraine medication for both acute and preventive treatment

New haven, conn., july 7, 2021 /prnewswire/ --- biohaven pharmaceutical holding company ltd.

BHVN Ratings Summary

BHVN Quant Ranking